These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32827203)

  • 1. Insightful exploring of microRNAs in psoriasis and its targeted topical delivery.
    Pradyuth S; Rapalli VK; Gorantla S; Waghule T; Dubey SK; Singhvi G
    Dermatol Ther; 2020 Nov; 33(6):e14221. PubMed ID: 32827203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of microRNAs in psoriasis: Immunological functions and potential biomarkers.
    Liu Q; Wu DH; Han L; Deng JW; Zhou L; He R; Lu CJ; Mi QS
    Exp Dermatol; 2017 Apr; 26(4):359-367. PubMed ID: 27783430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of microRNA in psoriasis: A review.
    Jiang X; Shi R; Ma R; Tang X; Gong Y; Yu Z; Shi Y
    Exp Dermatol; 2023 Oct; 32(10):1598-1612. PubMed ID: 37382420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphisms altering microRNA activity in psoriasis--a key to solve the puzzle of missing heritability?
    Pivarcsi A; Ståhle M; Sonkoly E
    Exp Dermatol; 2014 Sep; 23(9):620-4. PubMed ID: 24917490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of miR-145-5p contributes to hyperproliferation of keratinocytes and skin inflammation in psoriasis.
    Yan JJ; Qiao M; Li RH; Zhao XT; Wang XY; Sun Q
    Br J Dermatol; 2019 Feb; 180(2):365-372. PubMed ID: 30269330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis.
    Srivastava A; Nikamo P; Lohcharoenkal W; Li D; Meisgen F; Xu Landén N; Ståhle M; Pivarcsi A; Sonkoly E
    J Allergy Clin Immunol; 2017 Feb; 139(2):550-561. PubMed ID: 27568078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulated miR-187 contributes to the keratinocytes hyperproliferation in psoriasis.
    Tang L; He S; Zhu Y; Feng B; Su Z; Liu B; Xu F; Wang X; Liu H; Li C; Zhao J; Zheng X; Li C; Sun C; Lu C; Zheng G
    J Cell Physiol; 2019 Apr; 234(4):3661-3674. PubMed ID: 30607907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs: novel regulators in skin inflammation.
    Sonkoly E; Ståhle M; Pivarcsi A
    Clin Exp Dermatol; 2008 May; 33(3):312-5. PubMed ID: 18419608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as biological regulators in skin disorders.
    Singhvi G; Manchanda P; Krishna Rapalli V; Kumar Dubey S; Gupta G; Dua K
    Biomed Pharmacother; 2018 Dec; 108():996-1004. PubMed ID: 30372911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA miR-17-92 cluster is differentially regulated in the imiqumod-treated skin but is not required for imiqumod-induced psoriasis-like dermatitis in mice.
    Wu D; Bi X; Qu L; Han L; Yin C; Deng J; Dong Z; Mi QS; Zhou L
    Exp Dermatol; 2017 Jan; 26(1):82-84. PubMed ID: 27579777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs and potential target interactions in psoriasis.
    Zibert JR; Løvendorf MB; Litman T; Olsen J; Kaczkowski B; Skov L
    J Dermatol Sci; 2010 Jun; 58(3):177-85. PubMed ID: 20417062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Exploration of the Role of MicroRNAs in Psoriasis: A Systematic Review of the Literature.
    Huang RY; Li L; Wang MJ; Chen XM; Huang QC; Lu CJ
    Medicine (Baltimore); 2015 Nov; 94(45):e2030. PubMed ID: 26559308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus and Atopic Dermatitis.
    Domingo S; Solé C; Moliné T; Ferrer B; Cortés-Hernández J
    Cells; 2020 Dec; 9(12):. PubMed ID: 33321931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNAs in inflammatory skin diseases and their clinical implications.
    Løvendorf MB; Skov L
    Expert Rev Clin Immunol; 2015 Apr; 11(4):467-77. PubMed ID: 25719822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying targets for topical RNAi therapeutics in psoriasis: assessment of a new in vitro psoriasis model.
    Bracke S; Desmet E; Guerrero-Aspizua S; Tjabringa SG; Schalkwijk J; Van Gele M; Carretero M; Lambert J
    Arch Dermatol Res; 2013 Aug; 305(6):501-12. PubMed ID: 23775225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Inflammatory microRNAs for Treating Inflammatory Skin Diseases.
    Yang SC; Alalaiwe A; Lin ZC; Lin YC; Aljuffali IA; Fang JY
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2.
    Xu N; Brodin P; Wei T; Meisgen F; Eidsmo L; Nagy N; Kemeny L; Ståhle M; Sonkoly E; Pivarcsi A
    J Invest Dermatol; 2011 Jul; 131(7):1521-9. PubMed ID: 21412257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of an imbalanced miRNAs axis in pathogenesis of psoriasis: novel perspectives based on review of the literature.
    Wang MJ; Xu YY; Huang RY; Chen XM; Chen HM; Han L; Yan YH; Lu CJ
    Oncotarget; 2017 Jan; 8(3):5498-5507. PubMed ID: 27729619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum miRNA profiling identified miRNAs associated with disease severity in psoriasis.
    Ganguly T; Laha S; Senapati S; Chatterjee G; Chatterjee R
    Exp Dermatol; 2024 Jan; 33(1):e14973. PubMed ID: 37926911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40.
    Xu N; Meisgen F; Butler LM; Han G; Wang XJ; Söderberg-Nauclér C; Ståhle M; Pivarcsi A; Sonkoly E
    J Immunol; 2013 Jan; 190(2):678-88. PubMed ID: 23233723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.